Skip to product information

Human VCAM1 Active Recombinant Protein C-Fc Tag Lyophilized

Human VCAM1 Active Recombinant Protein C-Fc Tag Lyophilized

SKU:IHUVCAM1ARCFCLY100UG

Regular price $585.00
Sale price $585.00 Regular price
Sale Sold out

Questions about this product or need to customize? Contact us

View full details

Key facts

  • Species: Human
  • Target: VCAM1
  • Purity: > 95 % as determined by reducing SDS-PAGE..< 1.0 EU per ug of the protein as determined by the LAL method.
  • Source: HEK293 Cells
  • Storage Conditions: Lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8? for 2-7 days. Aliquots of reconstituted samples are stable at < -20? for 3 months.

In-depth information

Certificate of Analysis
Contact customer support to get your certificate of analysis

Contact Us

Human VCAM1 Recombinant Protein C-Fc Tag Lyophilized from Innovative Research has been recombinantly produced in HEK293 Cells. The protein formulation is lyophilized from sterile 100mM Glycine, 10mM NaCl, 50mM Tris, pH 7.5 with a purity of > 95 % as determined by reducing SDS-PAGE..

More Details:

  • Species: Human
  • Target: VCAM1
  • Purity: > 95 % as determined by reducing SDS-PAGE..< 1.0 EU per ug of the protein as determined by the LAL method.
  • Source: HEK293 Cells
  • Storage Conditions: Lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8? for 2-7 days. Aliquots of reconstituted samples are stable at < -20? for 3 months.

Vascular cell adhesion molecule 1 (VCAM-1), also known as CD106, is a cell surface sialoglycoprotein belonging to the immunoglobulin superfamily. Two forms of VCAM-1 with either six or seven extracellular Ig-like domains are generated by alternative splicing, with the longer form predominant. VCAM-1 is an endothelial ligand for very late antigen-4 (VLA-4) and α4ß7 integrin expressed on leukocytes, and thus mediates leukocyte-endothelial cell adhesion and signal transduction. VCAM-1 expression is induced on endothelial cells during inflammatory bowel disease, atherosclerosis, allograft rejection, infection, and asthmatic responses. During these responses, VCAM-1 forms a scaffold for leukocyte migration. VCAM-1 also activates signals within endothelial cells resulting in the opening of an "endothelial cell gate" through which leukocytes migrate. VCAM-1 has been identified as a potential anti-inflammatory therapeutic target, the hypothesis being that reduced expression of VCAM-1 will slow the development of atherosclerosis. In addition, VCAM-1-activated signals in endothelial cells are regulated by cytokines indicating that it is important to consider both endothelial cell adhesion molecule expression and function during inflammatory processes.Immune Checkpoint   Immunotherapy   Cancer Immunotherapy   Targeted Therapy

At Innovative Research, we provide reliable, consistent products that deliver reliable, consistent results.

For research use only.

This material is sold for in-vitro use only for research. This material is not suitable for human or animal use. While we make every effort to ensure the safety of our products, we recommend handling any biological materials with standard precautions as if capable of spreading infectious disease. The statements herein are offered for informational purposes only to be used solely for your consideration, investigation, and verification.

Please be aware the image pictured is for illustrative purposes only, and your product packaging and appearance may vary.

No Data Sheets available

Publications
and citations